A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates
- 1 June 2005
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (6) , 542-545
- https://doi.org/10.1016/j.ijantimicag.2004.10.016
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Susceptibilities of Campylobacter jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and TetracyclineAntimicrobial Agents and Chemotherapy, 2003
- In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with gyrA Mutations and the Function of the CmeABC Efflux PumpAntimicrobial Agents and Chemotherapy, 2003
- Selection and Characterization of Fluoroquinolone-Resistant Mutants ofCampylobacter jejuniUsing EnrofloxacinMicrobial Drug Resistance, 2002
- Functional characterisation of mycobacterial DNA gyrase: an efficient decatenaseNucleic Acids Research, 2002
- Single or Double Mutational Alterations of GyrA Associated with Fluoroquinolone Resistance inCampylobacter jejuniandCampylobacter coliMicrobial Drug Resistance, 2001
- Campylobacter jejuni Infections: Update on Emerging Issues and TrendsClinical Infectious Diseases, 2001
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Increased Resistance to Quinolones in Campylobacter jejuni: A Genetic Analysis of gyrA Gene Mutations in Quinolone‐Resistant Clinical IsolatesMicrobiology and Immunology, 1998
- The complete genome sequence of the gastric pathogen Helicobacter pyloriNature, 1997
- Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coliAntimicrobial Agents and Chemotherapy, 1996